MI
SLS icon

Motiv8 Investments’s SELLAS Life Sciences SLS Stock Holding History

Motiv8 Investments’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$0 Buy
+80
New +$155 ﹤0.01% 973

Other funds holding SLS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Motiv8 Investments's SLS Position: Q4 2025 in Review

Motiv8 Investments opened a new position in SELLAS Life Sciences (SLS) in Q4 2025: 80 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #973 among its holdings.

112 funds tracked by Wall St. Rank hold SLS as of Q4 2025.

  • Motiv8 Investments held 80 shares of SELLAS Life Sciences worth $0 as of Q4 2025.
  • SELLAS Life Sciences was a new Motiv8 Investments position in Q4 2025.
  • SELLAS Life Sciences made up ﹤0.01% of Motiv8 Investments's portfolio in Q4 2025, its #973 holding.
  • 112 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q4 2025.

Based on Motiv8 Investments's 13F filing for Q4 2025, filed 13 Feb 2026.